Investor’s Alert: Boardwalk Pipeline Partners, LP (NYSE:BWP), Knoll (NYSE:KNL), Sonic Corporation (NASDAQ:SONC), StemCells (NASDAQ:STEM)

Sterne Agee upgraded shares of BofI Holding, LP (NASDAQ:BOFI) from a neutral rating to a buy rating in a research report released on Thursday morning, TheFlyOnTheWall.com reports. Boardwalk Pipeline Partners, LP (NYSE:BWP) shares after opening at $15.50 moved to $16.26 on last trade day and at the end of the day closed at $15.72. Company price to sales ratio in past twelve months was calculated as 3.17 and price to cash ratio as 134.16. Boardwalk Pipeline Partners, LP (NYSE:BWP) showed a positive weekly performance of 11.65%.

Knoll Inc (NYSE:KNL) hit a new 52-week high on Thursday following a better than expected earnings announcement, AR Network reports. The company traded as high as $19.43 and last traded at $18.69, with a volume of 290,962 shares changing hands. Knoll Inc (NYSE:KNL) shares advanced 8.68% in last trading session and ended the day on $18.28. KNL return on equity ratio is recorded as 11.50% and its return on assets is 3.40%. Knoll Inc (NYSE:KNL) yearly performance is 18.86%.

Sonic Corporation (NASDAQ:SONC) was upgraded by equities researchers at Sterne Agee from a “neutral” rating to a “buy” rating in a research report issued on Wednesday, TheFlyOnTheWall.com reports. Sonic Corporation (NASDAQ:SONC) shares moved down -1.10% in last trading session and was closed at $20.61 while trading in range of $20.45 – $21.00 – Sonic Corporation (NASDAQ:SONC) year to date (YTD) performance is 2.08%.

StemCells, Inc. (Nasdaq:STEM) announced that it has completed enrollment in the Company’s Phase I/II clinical trial in spinal cord injury. The multi-national, open-label, Phase I/II trial is evaluating both safety and preliminary efficacy of StemCells, Inc.’s proprietary HuCNS-SC® human neural stem cells as a treatment for chronic spinal cord injury. StemCells Inc (NASDAQ:STEM) weekly performance is -1.75%. On last trading day company shares ended up $1.25. StemCells Inc (NASDAQ:STEM) distance from 50-day simple moving average (SMA50) is -12.49%. Analysts mean target price for the company is $2.75.